Lipitor

Ranbaxy and Pfizer Settle Lipitor Litigation Worldwide

Ranbaxy Will Market Generic Atorvastatin in the U.S. With 180 Days Exclusivity From Nov. 30, 2011 Agreement Also Resolves Caduet, Accupril Litigation in the US GURGAON, Harayana, India and PRINCETON, N.J., June 18 /PRNewswire/ -- Ranbaxy Laboratories Limited (Ranbaxy...

Simvastatin Leads Pfizer's Lipitor in Second-Line Patient Share for the Treatment of Dyslipidemia

Results from the ENHANCE Trial Impacting Physician Prescribing Patterns, According to a New Report from Decision Resources WALTHAM, Mass., May 13 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds...

Celebrex Plus Lipitor Could Fight Prostate Cancer

Combining painkiller with statin slows tumor progression, mouse study suggests MONDAY, April 14 (HealthDay News) -- Two widely used drugs -- one lowers cholesterol and one is an anti-inflammatory -- may be useful in controlling prostate cancer. New research being presented at the Am...

Statement of Robert Jarvik, MD, President and CEO of Jarvik Heart, Inc. Regarding the Lipitor DTC Advertisements

NEW YORK, Feb. 26 /PRNewswire/ -- The following is a statement being issued by Robert Jarvik, MD: A lifetime career in heart disease I remain deeply committed to alleviating suffering from heart disease, and I assure the public, from the bottom of my heart, that I have been sincere and hon...

PatientAssistance.com Releases the Top 20 Most Popular Searches for Patient Assistance Programs

...ALL XR (1183) 2. Lexapro (635) 3. LANTUS (556) 4. PLAVIX (533) 5. ADVAIR DISKUS (472) 6. Cymbalta (412) 7. NEXIUM (390) 8. lipitor (389) 9. ABILIFY (361) 10. SINGULAIR (345) 11. TOPAMAX (340) 12. LISINOPRIL (333) 13. LAMICTAL (327) 14. Suboxone (319) 15...

Statins don't lower risk of pneumonia in elderly

... SEATTLE Taking popular cholesterol-lowering statin drugs, such as lipitor (atorvastatin), does not lower the risk of pneumonia. That's the new finding from a study of more than 3,000 Group Health patients published online on...

Mini-Stroke Can Mean Major One Within Hours

...uction." Clopidogrel and aspirin are both aimed at the clots that can cause a stroke by blocking a brain artery. Statins are drugs such as Crestor, lipitor and Zocor that lower blood cholesterol levels. Brain images can illustrate why risk of a recurrence might be highest in the hours after a TIA or m...

Astellas Announces New Vice President of Marketing

...more than 18 years and last held the position of national sales director, Vista Rx. Most recently he was accountable for driving sales initiatives for lipitor and Caduet. Mr. Johnston earned his M.B.A. at Boston College and his undergraduate degree at Lafayette College . About Astellas Astellas P...

Acetaminophen, Cholesterol Drugs May Help Fight Stroke

...y issue of Lancet Neurology . Prior studies have suggested that the use of cholesterol-lowering statins -- which include the blockbusters Crestor, lipitor and Zocor -- can cut the risk of stroke for certain patients. in the new study, French researchers reviewed 24 studies involving more than 165,000 ...

More U.S. Kids Taking Diabetes, Blood Pressure Drugs

...ions, Liberman said. However, over the same period, prescriptions for cholesterol-lowering medications (which include statin drugs such as Crestor, lipitor and Zocor) dropped by almost 23 percent. The researchers speculate that this drop may have been due to controversy about prescribing these drugs to ch...

Lipitor in Medical Technology

Two New Imaging Studies Show Higher Dose Lipitor Stopped the Progression of Atherosclerosis

NEW ORLEANS--(BUSINESS WIRE)--Mar 26, 2007 - Pfizer said today that results from two new imaging trials showed that higher dose Lipitor stopped the progression of atherosclerosis in patients with coronary heart disease or familial hypercholesterolemia (FH). The trials, which were designed to invest...

Anthera's Varespladib Meets Primary Endpoint in Phase 2 FRANCIS Trial for the Treatment of Acute Coronary Syndrome

...-C). All patients in the FRANCIS trial received once daily doses of 80mg of lipitor (atorvastatin calcium), plus 500mg of varespladib or matching placebo. Var...dy, patients received therapeutic standard of care in addition to high dose lipitor (atorvastatin). In previous clinical trials, varespladib, a potent a...

Lipitor Provides Unprecedented Cardiovascular Risk Reductions in Diabetes Patients with Metabolic Syndrome and in Stroke Patients

...the criteria for metabolic syndrome in CARDS: -- lipitor 10 mg provided a significant 41 percent reduction ...t surgery, chest pain) compared with placebo. -- lipitor 10 mg provided a significant 61 percent reduction ...alysis was conducted to evaluate if treatment with lipitor 80 mg was associated with significant protection f...

Lipitor Significantly Lowered Hospitalization Costs for Patients with Heart Disease, Two New Analyses Show

...h the availability of low cost generics, intensive lipitor therapy is a good economic value," said Dr. Peter ...ring the five-year trial were 21 percent lower for lipitor 80 mg ($6,427 per patient) than for simvastatin 20...treatment of acute coronary syndrome patients with lipitor 80 mg is predicted to reduce cardiovascular events...

Lipitor Reduced the Risk of Coronary Events by Half and Stroke by Nearly One-Third in High-Risk Patients with Type 2 Diabetes Who Experienced a Recent Stroke

... WIRE)--Jun 25, 2007 - Pfizer announced today that lipitor (atorvastatin calcium) Tablets 80 mg reduced the r...tes with no known coronary heart disease, we found lipitor to be effective in reducing these risks." In this pre-specified analysis (n=794), lipitor reduced the risk of stroke by 30 percent, and coro...

Lipitor in Biological News

Statin therapy ineffective in breast cancer prevention

...he February issue of Cancer Prevention Research , a journal of the American Association for Cancer Research. Statins, sold under brand names like lipitor and Zocor, are primarily given to lower cholesterol and prevent heart disease, and prominent cardiologists almost universally agree that their use has...

Patients can report statins' adverse effects on new web site

...uch drugs ?atorvastatin (Lipitor) and simvastatin (Zocor) ?were #1 and #2 best-selling drugs in the country in 2004, with 75 million prescriptions for lipitor alone. Although pharmaceutical companies report that side effects of statin drugs are rare, there are some patients who experience serious consequence...

Lipitor in Biological Technology

Global Prescription Drugs Market to Cross $897 Billion by 2015, According to New Report by Global Industry Analysts, Inc.

...cond largest therapeutic class in 2009, followed closely by Lipid Regulators market. However, owing to a spate of patent expiries, including that of lipitor - the largest selling drug, lipid regulators are expected to witness a decline in revenues, and share of the global prescription drugs market. The...

Hovione Buys Pfizer's Loughbeg API Facility

... it has agreed with Pfizer to acquire their Loughbeg Active Pharmaceutical Ingredients (API) site in Ireland. This site manufactures intermediates for lipitor active pharmaceutical ingredient. The site has had a number of owners starting in 1984 with Angus Fine Chemicals, then Hickson & Welch, Wa...

Velcura Therapeutics, Inc. Teams with International Discovery Sourcing Consultants to Develop New Therapeutic Molecules for Cancer and Bone Disease

... ANN ARBOR, Mich., Feb. 4 /PRNewswire/ -- Pfizer's loss of some top talent, including lipitor pioneer Dr. Bob Sliskovic, is the gain of two Michigan companies teaming to help speed research to fight bone diseases such as multiple myeloma, metas...

Eisai/Pfizer's Aricept Owns a Dominating 42.4% Patient Share for First-Line Treatment of Alzheimer's Disease

...including add versus switch patterns) by lines of therapy. -- Progression of therapy from key 1st line products (e.g., initial treatment with lipitor to 2nd line, 3rd line; initial treatment with Zocor to 2nd line, 3rd line). -- Pathway to key therapies from previous therapies (e.g., how much ...

Novel Angiogenic Drugs, Including a Future Blockbuster from Genzyme, Could Revolutionize Treatment of Peripheral Arterial Disease

... Generic Erosion of Zocor and lipitor Will Cause Market Share of Statins to Drop Nearly...ent expiries of Merck's Zocor in 2006 and Pfizer's lipitor in 2010 will cause total statin market share to dr... be fastest for generic Zocor, which will overtake lipitor for prescriptions in the majority of newly diagnos...

Holiday Gift From Big Pharma

...ne that may be useful for the treatment of the heart disease atherosclerosis. Remember that Pfizer has a huge cardiovascular franchise with drugs like lipitor for high cholesterol ($8 billion in annual sales) and Norvasc for the treatment of blood pressure and angina. Pfizer is offering Esperion sharehol...

Line between big pharma, big biotech continues to blur

...1 billion or more) but the super-blockbuster drugs (drugs that sell $2 billion or more per year) and the mega-blockbuster drugs (the one drug, Pfizers lipitor for high cholesterol, sells more than $10 billion per year). Looking at sales of Big Pharma, though, isnt enough as it doesnt reveal the full pictu...

The world's leading biotech companies

...d products, it may even face a decline as key drugs lose their patent life (imagine what a disappearing patent does to a $12 billion/year drug such as lipitor which probably supplies 20-25% of Pfizer's annual sales and 30-35%, or more, of its profits). T-minus 34 days to the Olympics of Biotech: BIO-2006 ...

Big Pharma's continued hunger and search for new products

... Product/Company Disease Area Sales ($billions) % Growth 1. lipitor (Pfizer) Cholesterol Reduction $12.9 +6% 2. Plavix (Bristol-Myers Squ...are getting close to patent expiration in the coming years including Zocor, lipitor and others, and when this happens, you will see 80% or more of the revenue ...

First half of 2006 roundup: Big Pharma trumps biotech

...most likely to $300 million to $600 million/year, or a sales (and profit) loss of $2.4 billion to $2.7 billion. Imagine what will happen with Pfizer's lipitor with last year's sales of $13 billion (granted this is worldwide and Pfizer's patent expiration in different parts of the world varies). More recen...